Literature DB >> 2045189

Septicemia in long-term jugular hemodialysis catheters; eradicating infection by changing the catheter over a guidewire.

E J Carlisle1, P Blake, F McCarthy, S Vas, R Uldall.   

Abstract

By convention, septicemia occurring from an infected vascular catheter is treated with antibiotics and removal of the catheter. This approach, used with surgically implanted long-term catheters would be expected to result in loss of the vascular access site. During a 57 month period, we treated 21 episodes of septicemia secondary to infection of long term indwelling double lumen jugular venous catheters in our hemodialysis unit. Seventeen of 21 episodes were managed successfully by changing the catheter over a guidewire, thus preserving the access site. No relapse was observed after the antibiotic therapy was stopped. Only four patients required complete removal of the catheter and subsequent use of another site.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045189

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  3 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  Central venous catheters as a vascular access modality for pediatric hemodialysis.

Authors:  Fatina Ibrahim Fadel; Hesham Nabil Abdel Mooty; Hafez Mahmoud Bazaraa; Samar Mohamed Sabry
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

3.  Bacteremia in a pediatric hemodialysis unit secondary to Enterococcus fecalis.

Authors:  L C Hymes; B L Warshaw; B Clowers; P Newsome; H L Keyserling
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.